109 related articles for article (PubMed ID: 27646776)
1. The role of MDM4 SNP34091 A>C polymorphism in cancer: a meta-analysis on 19,328 patients and 51,058 controls.
Jin X; Zhao W; Zheng M; Zhou P; Niu T
Int J Biol Markers; 2017 Mar; 32(1):e62-e67. PubMed ID: 27646776
[TBL] [Abstract][Full Text] [Related]
2. MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects.
Xu C; Zhu J; Fu W; Liang Z; Song S; Zhao Y; Lyu L; Zhang A; He J; Duan P
Oncotarget; 2016 Nov; 7(44):71718-71726. PubMed ID: 27687591
[TBL] [Abstract][Full Text] [Related]
3. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract][Full Text] [Related]
4. MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.
Gansmo LB; Romundstad P; Birkeland E; Hveem K; Vatten L; Knappskog S; Lønning PE
Cancer Med; 2015 Dec; 4(12):1901-7. PubMed ID: 26471763
[TBL] [Abstract][Full Text] [Related]
5. The Correlation of Mouse Double Minute 4 (MDM4) Polymorphisms (rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576) with Cancer Susceptibility: A Meta-Analysis.
Chen J; Li X; Liu R; Xie Y; Liu Z; Xiong H; Li Y
Med Sci Monit; 2022 Mar; 28():e935671. PubMed ID: 35347102
[TBL] [Abstract][Full Text] [Related]
6. Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
Hashemi M; Sanaei S; Hashemi SM; Eskandari E; Bahari G
Clin Breast Cancer; 2018 Oct; 18(5):e883-e891. PubMed ID: 29439926
[TBL] [Abstract][Full Text] [Related]
7. The associations between MDM4 gene polymorphisms and cancer risk.
Wang MJ; Luo YJ; Shi ZY; Xu XL; Yao GL; Liu RP; Zhao H
Oncotarget; 2016 Aug; 7(34):55611-55623. PubMed ID: 27742919
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
[TBL] [Abstract][Full Text] [Related]
9. Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma.
Zhou L; Zhang X; Li Z; Zhou C; Li M; Tang X; Lu C; Li H; Yuan Q; Yang M
PLoS One; 2013; 8(5):e64331. PubMed ID: 23724042
[TBL] [Abstract][Full Text] [Related]
10. Association between the TP53BP1 rs2602141 A/C polymorphism and cancer risk: a systematic review and meta-analysis.
Liu L; Zhang D; Jiao JH; Wang Y; Wu JY; Huang DS
Asian Pac J Cancer Prev; 2014; 15(6):2917-22. PubMed ID: 24761925
[TBL] [Abstract][Full Text] [Related]
11. MDM4 genetic variants and risk of gastric cancer in an Eastern Chinese population.
Wang MY; Jia M; He J; Zhou F; Qiu LX; Sun MH; Yang YJ; Wang JC; Jin L; Wang YN; Wei QY
Oncotarget; 2017 Mar; 8(12):19547-19555. PubMed ID: 28099948
[TBL] [Abstract][Full Text] [Related]
12. CAV1 polymorphisms rs1049334, rs1049337, rs7804372 might be the potential risk in tumorigenicity of urinary cancer: A systematic review and meta-analysis.
Fan S; Meng J; Zhang L; Zhang X; Liang C
Pathol Res Pract; 2019 Jan; 215(1):151-158. PubMed ID: 30463805
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the association between ZBTB20 rs9841504 polymorphism and gastric and esophageal cancer susceptibility: a meta-analysis.
Shi J; Li W; Ding X
Int J Biol Markers; 2017 Mar; 32(1):e96-e101. PubMed ID: 27646774
[TBL] [Abstract][Full Text] [Related]
14. Association of XPG gene rs751402 polymorphism with gastric cancer risk: a meta-analysis in the Chinese population.
Liang J; Xu YY; Zhang C; Xia QR
Int J Biol Markers; 2018 May; 33(2):174-179. PubMed ID: 29148016
[TBL] [Abstract][Full Text] [Related]
15. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility.
Liu J; Tang X; Li M; Lu C; Shi J; Zhou L; Yuan Q; Yang M
Breast Cancer Res Treat; 2013 Jul; 140(1):151-7. PubMed ID: 23793604
[TBL] [Abstract][Full Text] [Related]
16. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
[TBL] [Abstract][Full Text] [Related]
17. A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibility.
Zhai Y; Dai Z; He H; Gao F; Yang L; Dong Y; Lu J
Oncotarget; 2016 Nov; 7(45):73935-73944. PubMed ID: 27738340
[TBL] [Abstract][Full Text] [Related]
18. Association of P2X7 A1513C (rs3751143) gene polymorphism with risk of tuberculosis: evidence from a meta-analysis.
Areeshi MY; Mandal RK; Panda AK; Haque S
Genet Test Mol Biomarkers; 2013 Sep; 17(9):662-8. PubMed ID: 23947898
[TBL] [Abstract][Full Text] [Related]
19. Association between manganese superoxide dismutase (MnSOD) polymorphism and prostate cancer susceptibility: a meta-analysis.
Li X; Shen M; Cai H; Liu K; Liu Y; Huang Z; Liang C; Deng X; Ye J; Zou Q; Li J
Int J Biol Markers; 2016 Dec; 31(4):e422-e430. PubMed ID: 27055786
[TBL] [Abstract][Full Text] [Related]
20. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
Shi XY; Shen Q
Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
